These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19896315)

  • 1. Detection of fluorine labeled herceptin using cellular (19)F MRI ex vivo.
    Bartusik D; Tomanek B
    J Pharm Biomed Anal; 2010 Mar; 51(4):894-900. PubMed ID: 19896315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of 19F magnetic resonance to study the efficacy of fluorine labeled drugs in the three-dimensional cultured breast cancer cells.
    Bartusik D; Tomanek B
    Arch Biochem Biophys; 2010 Jan; 493(2):234-41. PubMed ID: 19900396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of human MCF-7 breast carcinoma with antibody, cationic lipid and hyaluronic acid using ex vivo assays.
    Bartusik D; Tomanek B; Lattová E; Perreault H; Fallone G
    J Pharm Biomed Anal; 2010 Jan; 51(1):192-201. PubMed ID: 19709839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo assays of CEM cells cultured and treated in the three dimensional cultures.
    Bartusik D; Tomanek B; Lattová E; Perreault H; Fallone G
    Biomed Pharmacother; 2010 Jul; 64(6):390-5. PubMed ID: 20347572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of 19F magnetic resonance ex vivo imaging of three-dimensional cultured breast cancer cells to study the effect of delta-tocopherol.
    Bartusik D; Tomanek B; Siluk D; Kaliszan R; Fallone G
    Anal Biochem; 2009 Apr; 387(2):315-7. PubMed ID: 19454246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of interferon-gamma on Her-2/neu expression and antitumor activity of 131I-Herceptin in breast cancer cell lines].
    Fan YX; Luo RC; Fang YX; Yan X; Lu CW
    Ai Zheng; 2006 Apr; 25(4):443-6. PubMed ID: 16613677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex.
    Lattová E; Tomanek B; Bartusik D; Perreault H
    J Proteome Res; 2010 Mar; 9(3):1533-40. PubMed ID: 20063903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Killing effect of 131I-Herceptin on breast cancer cell lines in vitro].
    Lin J; Luo RC; Li AM; Zhang JY; Lü CW; Yan X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):663-6. PubMed ID: 15958303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [188Re-labeled herceptin inhibits proliferation of breast cancer cell line SKBR-3 in vitro].
    Li GP; Zhang YF; Wang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1455-7. PubMed ID: 17062351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
    Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Herceptin resistance in breast cancer cells.
    Kute T; Lack CM; Willingham M; Bishwokama B; Williams H; Barrett K; Mitchell T; Vaughn JP
    Cytometry A; 2004 Feb; 57(2):86-93. PubMed ID: 14750129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
    Ballangrud AM; Yang WH; Palm S; Enmon R; Borchardt PE; Pellegrini VA; McDevitt MR; Scheinberg DA; Sgouros G
    Clin Cancer Res; 2004 Jul; 10(13):4489-97. PubMed ID: 15240541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herceptin-platinum(II) binding complexes: novel cancer-cell-specific agents.
    Gao J; Liu YG; Liu R; Zingaro RA
    ChemMedChem; 2008 Jun; 3(6):954-62. PubMed ID: 18366039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of hematoporphyrin-herceptin photoimmunoconjugate for photoimmunotherapy].
    Chen L; Luo RC; Li LB; Yan X; Ding XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):355-7. PubMed ID: 16546747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Killing effect of Photofrin-Herceptin immunoconjugate on tumor cell lines in vitro].
    Qian XY; Luo RC; Li LB; Liao WJ; Luo YL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):975-8. PubMed ID: 16109553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivity.
    Jacoby C; Temme S; Mayenfels F; Benoit N; Krafft MP; Schubert R; Schrader J; Flögel U
    NMR Biomed; 2014 Mar; 27(3):261-71. PubMed ID: 24353148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in glycopeptides associated with herceptin treatment of human breast carcinoma mcf-7 and T-lymphoblastoid cells.
    Lattová E; Bartusik D; Spicer V; Jellusova J; Perreault H; Tomanek B
    Mol Cell Proteomics; 2011 Sep; 10(9):M111.007765. PubMed ID: 21610100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer.
    Kubo M; Morisaki T; Kuroki H; Tasaki A; Yamanaka N; Matsumoto K; Nakamura K; Onishi H; Baba E; Katano M
    Anticancer Res; 2003; 23(6a):4443-9. PubMed ID: 14666732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Killing effect of sequential Herceptin and adriamycin treatment on breast cancer cell line in vitro].
    Tan K; Fan YX; Miao JX; Lü CW; Yan X; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):234-6. PubMed ID: 16503541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.